7 First Eagle Investments Bio-Rad Laboratories Trades
First Eagle Investments's position in Bio-Rad Laboratories is currently worth $172 Million. The investor's estimated purchase price is $210 Million, resulting in a loss of 18%.
Avg closing price
Price range
Increased shares by 0.1% (+505 shares)
Q4 2024
Avg closing price
$339.22
Price range
$313.10
-
$374.01
Increased shares by 12.1% (+76.7 Thousand shares)
Q3 2024
Avg closing price
$317.17
Price range
$263.97
-
$344.60
Increased shares by 32296.9% (+634 Thousand shares)
Q2 2024
Avg closing price
$290.85
Price range
$268.26
-
$339.48
Increased shares by 310.0% (+1.49 Thousand shares)
Q1 2024
Avg closing price
$328.84
Price range
$304.11
-
$351.99
Increased shares by 4.6% (+21 shares)
Q4 2023
Avg closing price
$313.43
Price range
$269.37
-
$365.04
Increased shares by 139.8% (+267 shares)
Q3 2023
Avg closing price
$385.83
Price range
$350.25
-
$422.63
New holding (+191 shares)
Q2 2023
Avg closing price
$406.95
Price range
$359.49
-
$486.40
